Several laboratories have isolated and characterized conditional and nonconditional mutants of avian leukosis and sarcoma viruses (1-15, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [30] [31] [32] [33] [34] [35] . Such mutants have proven useful in identifying some viral genetic functions, but for an adequate definition of all viral genes several hundred mutants may be required. Thus, the numbers of avian tumor virus mutants which will be described in the literature are likely to rise rapidly over the next few years. Genetic work with avian RNA tumor viruses has been further stimulated by the discovery of recombination in this viral group (16, 28) . Recombination experiments will also greatly increase the number of genetically distinct viruses. In Mutant subgroup. The envelope subgroup of a mutant should also be given in the Materials and Methods section. Alternatively, this information may be included in the designation of individual mutants. It should then be appended, by using a hyphen, as a capital letter (Roman type) to mutant number or wildtype strain designation, e.g., LA335-C or LA335PR-C).
Double mutants. If a second mutation is introduced in a mutant virus, a supplementary number should be attached to the first mutant number by using a hyphen. This supplementary number is subject to the same restrictions stipulated for the mutant number (see above); i.e., it cannot be a mutant number already used by the same laboratory. Thus, ambiguity is avoided if the two mutations are separated by recombination. The second number may also include information on the category of the new mutant (e.g., LA335-tdl21 = a transformation defective derivative of LA335 isolated in laboratory LA). If the secondary mutation is isolated in a different laboratory, the appropriate laboratory code letter should precede the secondary mutant number (e.g., LA335-NY4 = a transformation-defective derivative isolated from LA335 in laboratory NY). Mutant viruses which are isolated as bona fide single mutations but are later found to carry multiple mutations should be marked by a lower-case Roman "m" (for multiple) after the mutant number [e.g., LA334m (21)]. If the two mutations of a double mutant are separated, e.g., by recombination, they should each be assigned a separate number. This could be done simply by adding a digit to the old mutant number, bearing in mind that the newly created numbers must not coincide with one previously used by the same laboratory (e.g., LA334m LA3341 and 3342). Table 2 summarizes the elements of the proposed mutant abbreviations with the aid of specific examples. The designations listed in the right-hand column contain the minimal RSVCT (10, 11, 12) on August 27, 2017 by guest http://jvi.asm.org/ Downloaded from VOL. 13, 1974 NOTES information which is necessary to identify a mutant, i.e., laboratory code letter and mutant number; both should always be used to refer to a mutant. The designations in the left-hand column of the table contain additional information, such as mutant category, wild-type strain, and subgroup, which may be important in the context of a particular experiment. The inclusion of this additional information in the mutant designation is optional; however, this information should be given in the Materials and Methods section.
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